These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 32748940)
1. Missed Opportunities for Human Immunodeficiency Virus (HIV) Testing During Injection Drug Use-Related Healthcare Encounters Among a Cohort of Persons Who Inject Drugs With HIV Diagnosed During an Outbreak-Cincinnati/Northern Kentucky, 2017-2018. Furukawa NW; Blau EF; Reau Z; Carlson D; Raney ZD; Johnson TK; Deputy NP; Sami S; McClung RP; Neblett-Fanfair R; de Fijter S; Ingram T; Thoroughman D; Vogel S; Lyss SB Clin Infect Dis; 2021 Jun; 72(11):1961-1967. PubMed ID: 32748940 [TBL] [Abstract][Full Text] [Related]
2. HIV and HCV testing at clinical encounters among people who inject drugs, 2013-2018-Opportunities for increased testing and prevention. Evans KN; Vettese T; Wortley PM; Gandhi AP; Bradley H J Viral Hepat; 2023 Nov; 30(11):848-858. PubMed ID: 37726974 [TBL] [Abstract][Full Text] [Related]
3. HIV detection by an emergency department HIV screening program during a regional outbreak among people who inject drugs. Faryar KA; Ancona RM; Reau Z; Lyss SB; Braun RS; Rademaker T; Sickles RK; Lyons MS PLoS One; 2021; 16(5):e0251756. PubMed ID: 34003855 [TBL] [Abstract][Full Text] [Related]
4. Injection drug use practices and HIV infection among people who inject drugs in Kigali, Rwanda: a cross-sectional study. Twahirwa Rwema JO; Nizeyimana V; Prata NM; Okonkwo NE; Mazzei AA; Muhirwa S; Rukundo A; Lucas L; Niyigena A; Makuza JD; Beyrer C; Baral SD; Kagaba A Harm Reduct J; 2021 Dec; 18(1):130. PubMed ID: 34911554 [TBL] [Abstract][Full Text] [Related]
5. Risk factors for loss to follow-up of persons who inject drugs enrolled at syringe services programs in Kentucky. Soria J; Johnson T; Collins J; Corby-Lee G; Thacker J; White C; Hoven A; Thornton A Int J Drug Policy; 2021 Sep; 95():103255. PubMed ID: 33853033 [TBL] [Abstract][Full Text] [Related]
6. Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California. Horyniak D; Wagner KD; Armenta RF; Cuevas-Mota J; Hendrickson E; Garfein RS Int J Drug Policy; 2017 Sep; 47():9-17. PubMed ID: 28683432 [TBL] [Abstract][Full Text] [Related]
7. Human Immunodeficiency Virus and Hepatitis C Virus Infection Testing Among Commercially Insured Persons Who Inject Drugs, United States, 2010-2017. Bull-Otterson L; Huang YA; Zhu W; King H; Edlin BR; Hoover KW J Infect Dis; 2020 Aug; 222(6):940-947. PubMed ID: 32002537 [TBL] [Abstract][Full Text] [Related]
8. Understanding the Intersection of Behavioral Risk and Social Determinants of Health and the Impact on an Outbreak of Human Immunodeficiency Virus Among Persons Who Inject Drugs in Philadelphia. Kim MM; Conyngham SC; Smith C; Higgins D; Nassau T; Terrell C; Brady KA J Infect Dis; 2020 Sep; 222(Suppl 5):S250-S258. PubMed ID: 32877552 [TBL] [Abstract][Full Text] [Related]
9. Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets. Janjua NZ; Islam N; Kuo M; Yu A; Wong S; Butt ZA; Gilbert M; Buxton J; Chapinal N; Samji H; Chong M; Alvarez M; Wong J; Tyndall MW; Krajden M; Int J Drug Policy; 2018 May; 55():31-39. PubMed ID: 29482150 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis C Virus Infection Preceding an Outbreak of Human Immunodeficiency Virus Among Persons Who Inject Drugs-Kanawha County, West Virginia, 2019-2021. Hudson AG; Bonacci RA; Moorman AC; Penley M; Wilson SM; Hoffman JL; Thomasson ER; McClung RP; Bixler D Clin Infect Dis; 2023 Feb; 76(3):e752-e754. PubMed ID: 35903004 [TBL] [Abstract][Full Text] [Related]
11. Injection of cocaine is associated with a recent HIV outbreak in people who inject drugs in Luxembourg. Arendt V; Guillorit L; Origer A; Sauvageot N; Vaillant M; Fischer A; Goedertz H; François JH; Alexiev I; Staub T; Seguin-Devaux C PLoS One; 2019; 14(5):e0215570. PubMed ID: 31095576 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the scale-up of HIV testing among people who inject drugs in Scotland in the context of an ongoing HIV outbreak. Trayner KMA; Palmateer NE; McAuley A; Metcalfe R; Goldberg DJ; Peters E; Craik J; Gunson RN; Thain D; Carter D; Hutchinson SJ Int J Drug Policy; 2021 Oct; 96():103304. PubMed ID: 34325970 [TBL] [Abstract][Full Text] [Related]
13. Low HIV testing among persons who inject drugs-National HIV Behavioral Surveillance, 20 U.S. cities, 2012. Cooley LA; Wejnert C; Spiller MW; Broz D; Paz-Bailey G; Drug Alcohol Depend; 2016 Aug; 165():270-4. PubMed ID: 27323649 [TBL] [Abstract][Full Text] [Related]
14. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique. Semá Baltazar C; Horth R; Boothe M; Sathane I; Young P; Chitsondzo Langa D; Condula M; Ricardo H; Dengo Baloi L; Cummings B; Schaad N; Gouveia L; Teodoro E; Raymond HF BMC Infect Dis; 2019 Dec; 19(1):1022. PubMed ID: 31791273 [TBL] [Abstract][Full Text] [Related]
15. Responding to Outbreaks of Human Immunodeficiency Virus Among Persons Who Inject Drugs-United States, 2016-2019: Perspectives on Recent Experience and Lessons Learned. Lyss SB; Buchacz K; McClung RP; Asher A; Oster AM J Infect Dis; 2020 Sep; 222(Suppl 5):S239-S249. PubMed ID: 32877545 [TBL] [Abstract][Full Text] [Related]
16. Brief Report: HIV Diagnoses Among Persons Who Inject Drugs by the Urban-Rural Classification-United States, 2010-2018. Lyss SB; Zhang T; Oster AM J Acquir Immune Defic Syndr; 2021 Nov; 88(3):238-242. PubMed ID: 34310448 [TBL] [Abstract][Full Text] [Related]
17. HIV Testing and awareness of HIV status among people who inject drugs in greater Kuala Lumpur, Malaysia. Bazazi AR; Vijay A; Crawford FW; Heimer R; Kamarulzaman A; Altice FL AIDS Care; 2018 Jan; 30(1):59-64. PubMed ID: 28803503 [TBL] [Abstract][Full Text] [Related]
18. The cost of a late-detected outbreak among people who inject drugs. A modeling study. Gountas I; Hatzakis A; Nikolopoulos G; Touloumi G; Souliotis K Int J Drug Policy; 2021 Feb; 88():103032. PubMed ID: 33212371 [TBL] [Abstract][Full Text] [Related]
19. Human Immunodeficiency Virus Testing, Diagnosis, Linkage to Care, and Prevention Services Among Persons Who Inject Drugs, United States, 2012-2017. Rao S; Song W; Mulatu MS; Seena E; Essuon A; Heitgerd J J Infect Dis; 2020 Sep; 222(Suppl 5):S268-S277. PubMed ID: 32877556 [TBL] [Abstract][Full Text] [Related]
20. Missed opportunities for prevention: prevalence and incidence of human immunodeficiency virus and hepatitis C virus diagnoses among a cohort of individuals discharged from an urban hospital with injection drug-related diagnoses, 2012-2019. Evans KN; Vettese T; Wortley PM; Gandhi AP; Bradley H Ann Epidemiol; 2023 Apr; 80():69-75.e2. PubMed ID: 36791871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]